Cargando…
Prevalence and Prognostic Implications of PD-L1 Expression in Soft Tissue Sarcomas
Background: PD-L1 expression differs from 19 to 92% in various cancer subtypes. Its expression carries a worse prognostic value in various malignancies and could also be used as a predictive marker for immune checkpoint inhibitor response. This study aimed to explore the prevalence of PD-L1 expressi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280295/ https://www.ncbi.nlm.nih.gov/pubmed/34276259 http://dx.doi.org/10.3389/pore.2021.1609804 |